Matteo De Pastena
University of Verona, Azienda Ospedaliera Universitaria Integrata Verona
Papers
26
Total Citations
1,123
H-Index
13
About
Matteo De Pastena is a leading pancreatic surgeon and researcher whose work has fundamentally shaped the modern approach to minimally invasive pancreatic surgery. His primary research focus is on comparing the safety, oncological efficacy, and cost-effectiveness of minimally invasive versus open techniques for pancreatic resections, particularly distal pancreatectomy and pancreatoduodenectomy. Dr. De Pastena is best known for his central role in the landmark DIPLOMA trial, the first international randomized non-inferiority trial demonstrating that minimally invasive distal pancreatectomy is a safe and oncologically sound option for patients with pancreatic ductal adenocarcinoma (over 280 citations). He also developed the updated Alternative Fistula Risk Score (ua-FRS), a critical tool for predicting postoperative pancreatic fistula after minimally invasive pancreatoduodenectomy (nearly 200 citations). His extensive comparative analyses of robotic versus laparoscopic approaches, including large multicenter studies and learning curve evaluations, have provided essential guidance for surgical teams adopting these technologies. With over 900 total citations across his most influential works, Dr. De Pastena’s research continues to drive evidence-based improvements in patient outcomes and quality of life after pancreatic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Robotic <i>versus</i> laparoscopic distal pancreatectomy: multicentre analysis121 citations · 2021
- 4
- 5
- 6
- 7
- 8
- 9
- 10Robotic spleen-preserving distal pancreatectomy: the Verona experience31 citations · 2020